CSI Market
Sign In | Register

Cymabay Therapeutics Inc (CBAY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CBAY Annual Balance Sheets →
Balance sheet data covering Cymabay Therapeutics Inc–Dec 31 2022 offers a view into how Dec 31 2023's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent206.54
Available-for-sale Securities, Debt Securities, Current MA187.72
Cash & Short-term Investments393.00
Prepaid Expense And Other Assets Current9.55
Total Current Assets403.80
Equipment/Property/Plant Net0.47
Long-term investments21.93
Other Assets, Noncurrent10.00
Operating Lease Right Of Use Asset-
Total Assets434.69
Liabilities
Accounts Payable, Current AC3.83
Other Accrued Liabilities, Current15.69
Other Liabilities, Current15.63
Deferred Revenue, Current DE1.69
Total Current Liabilities36.84
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE1.10
Other liabilities, Noncurrent104.49
Accrued Research And Development Expenses5.63
Operating Lease Liability Noncurrent-
Total Liabilities142.43
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,270.33
Retained Earnings / Accumulated Deficit-978.23
Other Equity0.14
Common Stockholder's Equity292.26
Total Stockholder's Equity292.26
Liabilities & Stockholder's Equity434.69
4 historic quarters locked

Sign in to unlock the full Cymabay Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Cymabay Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: February 28, 2024
  • Source: d719301d10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-24-050758

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.